The finding of equivalence in diagnostic accuracy raises hopes for an eventual noninvasive means for reliable early diagnosis of multiple sclerosis.
Cortical changes other than demyelination appear to exert more influence on conventional MRI modalities, finds a new postmortem MRI study. Better acquisition and post-processing methods are needed.
The lead author of a new consensus statement on deep gray matter injury shares potential implications for the characterization, monitoring and treatment of MS.
A leading neuroradiologist shares insights from six years of using this advanced imaging technology for research and clinical purposes in conditions from multiple sclerosis to brain tumor.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A novel PET radiotracer binds preferentially to myelin to provide unique brain imaging advantages over existing MRI methods. Here’s an overview of its backstory and clinical potential.
Myelin PET offers quantitative imaging of brain microstructure that goes beyond what’s seen with current MRI methods. Here’s how we’re using it in epilepsy — and how we’ll soon be using it in other CNS diseases.